CNS Pharmaceuticals(CNSP)

0.2140 0.0040 1.9048%

今开:0.2099昨收:0.21
最高:0.2198 最低:0.2
涨停价:0.0跌停价:0.0
总市值:2275875.0

CNS Pharmaceuticals的热门讨论

首次持股声明

CNS Pharmaceuticals(CNSP)02-06 23:35

$CNS Pharmaceuticals(CNSP)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001683168-24-000704  Size: 2 KB 网页链接查看全文

其他

CNS Pharmaceuticals(CNSP)03-29 05:35

$CNS Pharmaceuticals(CNSP)$ PRE 14A Other preliminary proxy statements Accession Number: 0001683168-24-001829  Act: 34  Size: 517 KB 网页链接查看全文

股东委托书协议

CNS Pharmaceuticals(CNSP)04-10 18:05

$CNS Pharmaceuticals(CNSP)$ DEF 14A Other definitive proxy statements Accession Number: 0001683168-24-002244  Act: 34  Size: 1 MB 网页链接查看全文

当期报告

CNS Pharmaceuticals(CNSP)04-15 18:15

$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001683168-24-002359  Act: 34  Size: 4 MB 网页链接查看全文

持股变动声明

CNS Pharmaceuticals(CNSP)04-11 09:55

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002286  Size: 7 KB 网页链接查看全文

生效批准

CNS Pharmaceuticals(CNSP)01-30 19:05

$CNS Pharmaceuticals(CNSP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000237  Act: 33  Size: 1 KB 网页链接查看全文

持股变动声明

CNS Pharmaceuticals(CNSP)02-06 23:35

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-000709  Size: 5 KB 网页链接查看全文

超过5%股东持股披露「修订」

CNS Pharmaceuticals(CNSP)02-15 03:35

$CNS Pharmaceuticals(CNSP)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-001223  Act: 34  Size: 90 KB 网页链接查看全文

持股变动声明

CNS Pharmaceuticals(CNSP)04-11 09:55

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002283  Size: 7 KB 网页链接查看全文

持股变动声明

CNS Pharmaceuticals(CNSP)04-11 09:55

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002290  Size: 7 KB 网页链接查看全文

1 2 3

CNS Pharmaceuticals的公告

当期报告

$CNS Pharmaceuticals(CNSP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001683168-24-002359  Act: 34  Size: 4 MB 网页链接

持股变动声明

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002283  Size: 7 KB 网页链接

持股变动声明

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002285  Size: 7 KB 网页链接

持股变动声明

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002290  Size: 7 KB 网页链接

持股变动声明

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002287  Size: 7 KB 网页链接

持股变动声明

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002286  Size: 7 KB 网页链接

持股变动声明

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002284  Size: 7 KB 网页链接

持股变动声明

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002288  Size: 7 KB 网页链接

持股变动声明

$CNS Pharmaceuticals(CNSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-24-002289  Size: 7 KB 网页链接

股东委托书协议

$CNS Pharmaceuticals(CNSP)$ DEF 14A Other definitive proxy statements Accession Number: 0001683168-24-002244  Act: 34  Size: 1 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20